ArticleCardio-oncology (London, England)2022

Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study.

Charlie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.